Events Seminar: High Efficiency Cell Engineering at UCLA

Seminar: High Efficiency Cell Engineering at UCLA

Join us at UCLA for a Breakfast & Learn on High Efficiency Cell Engineering

Wednesday, October 2, 2024
10:00 - 11 :00 AM (PT)

Register for the event

If you are unable to attend in-person

In-Person Event Details

Location:
Magnify Incubator, CNSI
5^th Floor Presentation Space (Room 5200)
570 Westwood Plaza
Los Angeles, CA 90095

Join us for the UCLA High Efficiency Cell Engineering Breakfast & Learn on Wednesday, October 2^nd, from 10:00 - 11:00 AM at the Magnify Incubator, CNSI.

Start your morning with insights into how MaxCyte’s advanced electroporation platforms are revolutionizing gene editing in hematopoietic stem cells (HSCs) for applications like CRISPR and Base Editing.

Learn about recent breakthroughs in treating blood disorders, including Sickle Cell Disease and immune deficiencies, with cutting-edge CRISPR and Cas9 technologies.

Space is limited—reserve your spot today!

Breakfast is on us! We value your time, and to keep the focus on learning, we're providing a complimentary breakfast for all on-site attendees. If you have any questions related to this event, please contact Kyle Franks ([email protected]).

Speakers

Zulema Romero Garcia, PhD

Assistant Adjunct Professor, Department of Microbiology, Immunology and Molecular Genetics at the University of California, Los Angeles

Zulema Garcia Romero, PhD, completed her doctorate at the University Granada (Spain) in 2009 and completed her postdoctoral fellowship work with Donald Kohn, PhD, in 2015 at UCLA. During her postdoctoral fellowship, she trained in experimental hematology, viral vectors, gene-editing methods and GMP cell processing. She is currently an Assistant Adjunct Professor in the Department of Microbiology, Immunology and Molecular Genetics at UCLA. Currently, her central research work aims at enhancing gene editing by investigating efficacy and toxicity from editing protocols; studying the relationship between hematopoietic stem cell (HSC) cycle status and gene-editing outcomes and engraftment of the long-term HSCs in different immunodeficient mouse models as well as translating research-scale methods of editing to GMP-compatible, clinical-scale manufacturing.

Kyle Franks

Strategic Business Manager
MaxCyte, Inc.

Kyle Franks is the Strategic Business Manager for MaxCyte's Southwest region. Kyle received his degree from UC Santa Cruz in Chemistry; his research explored the structural activation mechanisms of circadian transcription factors. Kyle is a proven partner in supporting organizations from research to commercialization, connecting scientists, manufacturing, and regulatory professionals to achieve their goals.

Please fill form below to register for the in-person seminar.